We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




RF Ablation Shows Promise for Treating Breast Tumors

By HospiMedica staff writers
Posted on 09 Jan 2003
A small trial has found that radiofrequency (RF) ablation may treat some breast tumors without surgery and with little cosmetic harm. More...
The results were reported at the Breast Cancer Symposium in San Antonio (TX, USA).

In the trial, 30 women with early stage breast cancer who were already scheduled to have a mastectomy or lumpectomy agreed to have RF ablation of their tumor first. When their breast tissue was removed, researchers examined whether the tumors has been destroyed. In 28 of the women (93%), the tumors were completely eradicated when the lesion had been accurately targeted by ultrasound.

The M.D. Anderson Cancer Center (Houston, TX, USA) participated in the trial and will start a new 20-patient trial of the technique within several months. The women in this trial will receive only RF ablation and will be closely monitored for several years. Researchers say the tumors should be two centimeters or smaller in size, clearly identifiable by ultrasound, and not up against the skin or chest wall.

"Radiofrequency ablation is a nonsurgical lumpectomy that may be used to treat small invasive breast cancers in the future,” says Eva Singletary, M.D., a surgeon at M.D. Anderson who is pioneering use of the technique. "It has the potential to offer local control of cancer with an even better cosmetic result than lumpectomy.”





Related Links:
M.D. Anderson

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.